Apotex and Grünenthal have finalised a licensing agreement granting Apotex exclusive Canadian rights to Nebido, a long-acting ...

Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, and Grünenthal, a global leader in pain management ...

Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced they have entered into a licensing ...

Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical ...

German family-owned pain specialist Grünenthal has entered into a licensing agreement whereby Canada-based Apotex will have the exclusive Canadian rights to Nebido (testosterone undecanoate), a ...

By Dr. Priyom Bose, Ph.D. Drawing on 52 studies, this review challenges assumptions about athletic advantage between cis- and transgender athletes, while highlighting major evidence gaps in elite and ...

Under the agreement, Searchlight Pharma, Apotex's branded medicine division, will pursue marketing authorization and will market and distribute the product in Canada upon regulatory approval.

Every item on this page was chosen by an ELLE editor. We may earn commission on some of the items you choose to buy. For those who need it—men who have low levels of testosterone with symptoms such as ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Whether you’ve searched the internet far and wide for the best ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...